Clinical trial professionals and academic organizations have long been cautious about the safety and legal liability of including pregnant or lactating participants in studies. But a recent report from the National Academies of Sciences, Engineering and Medicine (NASEM) finds limited evidence to support those fears.1 The report also warns that the lack of evidence available to these patients and their doctors about using a drug or vaccine poses greater potential harm than including them in research would.